Sphingolipids in COPD

Raja Chandra Chakinala, Akshay Khatri, Kriti Gupta, Kengo Koike, Oleg Epelbaum

Source: Eur Respir Rev, 28 (154) 190047; 10.1183/16000617.0047-2019

Journal Issue: December

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Raja Chandra Chakinala, Akshay Khatri, Kriti Gupta, Kengo Koike, Oleg Epelbaum. Sphingolipids in COPD. Eur Respir Rev, 28 (154) 190047; 10.1183/16000617.0047-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Chaperonins in COPD Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
Exacerbations of COPD Source: Eur Respir Rev, 27 (147) 170103; 10.1183/16000617.0103-2017 Year: 2018
Exacerbations of asthma and COPD Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017
Exacerbations of asthma and COPD Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018
Exacerbations of asthma and COPD Source: ERS Skills Course 2016 Year: 2016
Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007
Comorbidities in COPD Source: Eur Respir J 2009; 34: 1497-1498 Year: 2009
Comorbidities of COPD Source: Eur Respir Rev 2013; 22: 454-475 Year: 2013
Airway glucose in COPD exacerbations Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Exacerbations of COPD and treatment Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018
Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
COPD Phenotypes and Comorbidities Source: International Congress 2017 – COPD biomarkers Year: 2017
Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012
Macrolides targeting multiple immune pathways in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013
COPD Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018
COVID-19 and COPD Source: Eur Respir J, 56 (2) 2002108; 10.1183/13993003.02108-2020 Year: 2020
COPD Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019